Finance

Lists
BTAI:NASDAQ
BioXcel Therapeutics Inc
$0.83
+4.46%
(+0.035) 1D
$0.82
-0.89% (-0.0074)
Pre-market
Closed: Aug 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BTAI...
Open
$0.79
High
$0.86
Low
$0.79
Mkt. cap
25.97M
Avg. vol.
1.11M
Volume
15.90K
52-wk high
$5.60
52-wk low
$0.74
EPS
-$3.78
Beta
0.32
Shares outstanding
31.30M
No. of employees
29
Open
$0.79
High
$0.86
Low
$0.79
Mkt. cap
25.97M
Avg. vol.
1.11M
Volume
15.90K
52-wk high
$5.60
52-wk low
$0.74
EPS
-$3.78
Beta
0.32
Shares outstanding
31.30M
No. of employees
29
News stories
From web sources and news partners
About BioXcel Therapeutics Inc
CEO-
Employees29
Founded2017
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Websitebioxceltherapeutics.com
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$5.00
+504.3%
04/10/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
$1.00
+20.9%
03/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+1,954.6%
03/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
98.00K
256.00K
206.00K
182.00K
Cost of goods sold
11.00K
32.00K
283.00K
22.00K
Cost of revenue
11.00K
32.00K
283.00K
22.00K
Research and development expenses
8.74M
6.70M
2.96M
3.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.38M
3.80M
7.19M
7.19M
Operating expense
14.12M
10.51M
10.15M
10.35M
Total operating expenses
14.13M
10.54M
10.43M
10.38M
Operating income
-14.03M
-10.28M
-10.22M
-10.19M
Other non operating income
-12.55M
1.81M
1.52M
-394.00K
EBT including unusual items
-30.91M
-12.54M
-12.69M
-14.71M
EBT excluding unusual items
-30.72M
-12.54M
-12.69M
-14.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-30.91M
-12.54M
-12.69M
-14.71M
Net profit margin
-31,541.84%
-4,900.39%
-6,160.68%
-8,084.07%
Earnings per share
-2.16
-
-0.54
-0.49
Interest and investment income
236.00K
321.00K
211.00K
131.00K
Interest expense
-4.37M
-4.40M
-4.20M
-4.26M
Net interest expenses
-4.14M
-4.08M
-3.99M
-4.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.96M
-10.21M
-10.16M
-10.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps